← Back to all signals
RESEARCH PAPER ANALYSIS

Long-term efficacy and safety of cannabidiol in patients with treatment-resistant focal epilepsies treated in the Expanded Access Program.

AI interpretation is pending for this paper.

Open original publication →
PMID40673944
JournalEpilepsia
Publication Date2025-07-17
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

OBJECTIVE: Cannabidiol (CBD) treatment was associated with long-term seizure reduction in patients with various treatment-resistant epilepsies who participated in the CBD Expanded Access Program. A phase 3 trial showed CBD effectively treats tuberous sclerosis complex (TSC)-associated seizures, which are primarily of focal origin. However, the effectiveness of CBD in non-TSC focal epilepsies is not well reported. Here, we evaluate CBD treatment outcomes among patients with a variety of focal epilepsies, including TSC. METHODS: Patients received plant-derived highly purified CBD (Epidiolex; 100 mg/mL oral solution) doses starting at 2-10 mg/kg/day and titrated up to each patient's limit or to a maximum of 25-50 mg/kg/day. CBD effectiveness was assessed by the median percentage change from baseline in monthly frequency of focal and total seizures and by responder rates through 144 weeks of treatment. Safety data were reported for the full follow-up period. RESULTS: Of 140 patients with focal epilepsies, 33 (24%) had TSC and 107 (76%) had other focal epilepsies, including cortical dysplasia (14%), frontal lobe epilepsy (10%), and malformation of cortical development (9%). Median age was 11.9 years (range = 2-31) in the TSC group and 17.8 years (range = 2-73) in the non-TSC group. Median CBD daily dose was comparable between TSC and non-TSC groups (25 and 23 mg/kg/day, respectively). CBD treatment was associated with a median reduction from baseline of 51%-87% in focal seizures and 44%-87% in total seizures in the TSC group and 46%-75% and 45%-71% in the non-TSC group, respectively. Responder rates were similar for both groups. Adverse events occurred in 91% of the TSC group and 96% of the non-TSC group. SIGNIFICANCE: Open-label CBD treatment was associated with sustained seizure reduction through 144 weeks, with a consistent safety profile in patients with treatment-resistant focal epilepsies, regardless of epilepsy type.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Orofacial Cleft Characteristics in Van der Woude Syndrome: A Retrospective Study in Japan. Congenital anomalies 61.5 2 Spectrum of oral and maxillofacial pathologies in pediatric patients: A decade-long institutional study in South Kerala. Indian journal of pathology & microbiology 49.0 3 A clinicopathological study of gonadal tumors in differences in sex development: Experience from a tertiary care centre. Indian journal of pathology & microbiology 58.4 4 Suprasellar neuroblastoma in an adult: Challenges in neuropathological diagnosis. Indian journal of pathology & microbiology 45.5 5 Hypothalamic hamartoma in a child with Pallister-Hall syndrome: Report of a rare lesion successfully managed with multidisciplinary approach. Indian journal of pathology & microbiology 56.0 6 Orbital neuromuscular choristoma (benign triton tumor) presenting as a painful blind eye: A rare case report. Indian journal of pathology & microbiology 45.5 7 Physical activity and health-related quality of life in women with polycystic ovary syndrome attending fertility clinics in Sri Lanka: a cross-sectional study. BMC women's health 64.0 8 SFRP2+ fibroblasts orchestrate post-chemotherapy remodeling and define a tumor-driven prognostic program, NBTRP, in adrenal neuroblastoma. Cell death & disease 66.14 9 Retrospective CT imaging findings of pediatric colorectal carcinoma with correlative outcomes: a case series. BMC pediatrics 54.5 10 TRAIL orchestrates ThINKK-induced NK cell cytotoxicity against childhood acute lymphoblastic leukemia. Cancer immunology, immunotherapy : CII 61.42 11 Three-dimensional imaging characteristics of odontomas using cone-beam computed tomography: a clinical retrospective study. BMC oral health 63.0 12 Familial tailgut cysts in two sisters presenting with sacral dimple sign: a case report. Journal of medical case reports 49.0 13 Effectiveness of health mediation to promote organised cancer screening among underserved and under-screened populations in Marseille, France: findings from a repeated cross-sectional survey. BMC public health 62.0 14 Subependymal Giant Cell Astrocytoma Mimicking Recurrent Ependymoma: Imaging Clues to the Diagnosis of Tuberous Sclerosis Complex. Cureus 54.0 15 Characterization of chemoresistant cell populations improves risk stratification and therapy prediction in pediatric acute myeloid leukemia. Nature communications 74.0 16 The minipig as a programmable translational platform for experimental oncofertility. Frontiers in oncology 54.1 17 Epidemiology and outcomes in pediatric neuroblastoma: a US population-based study. Frontiers in medicine 70.0 18 Long-term endocrine and reproductive outcomes in female adolescent and young adult survivors after hematopoietic stem cell transplantation for hematological malignancies during childhood or adolescence. Frontiers in endocrinology 67.5 19 Case Report: Diagnostic dilemma: rebound thymic hyperplasia mimicking mediastinal relapse following chemoimmunotherapy in pediatric jejunal Burkitt lymphoma. Frontiers in immunology 61.74 20 Mosaic RASopathies: comprehensive genetic and clinicopathological analysis for diagnosis and management. Frontiers in cell and developmental biology 58.5 21 Primary bronchial fibrous histiocytoma mimicking refractory asthma in a child: A fatal case of misdiagnosis and airway obstruction. Respiratory medicine case reports 61.62 22 Primary pulmonary small cell carcinoma in a 13-year-old boy with prolonged second-hand tobacco smoke exposure: A rare pediatric lung malignancy with a review of reported cases and registry data. Respiratory medicine case reports 64.3 23 Rapidly progressive adult-onset hydroa vacciniforme-like lymphoproliferative disorder associated with Epstein-Barr virus: a case report. Leukemia research reports 51.1 24 Immunohistochemical analysis of phospho-ERK1/2 in odontogenic cysts. Journal of applied oral science : revista FOB 37.0 25 Exercise against cancer: recent advances and open questions. Trends in cancer 70.7 26 Childhood malignancies in inborn errors of immunity: a multicenter cohort study. European journal of pediatrics 68.1 27 Effect of implementation of a clinical checklist on the evaluation of constitutional mismatch repair deficiency in a neurofibromatosis clinic. Journal of community genetics 73.7 28 Tumour-anchored Purkinje-mediated ventricular tachycardia in a child with cardiac rhabdomyoma. Cardiology in the young 33.5 29 Angiographic findings, revascularisations and mortality in childhood cancer survivors with ischaemic heart disease. JNCI cancer spectrum 65.4 30 Lived Experience of Treatment-Related Late Effects After Childhood and Adolescent Cancer. Journal of adolescent and young adult oncology 59.24 31 A Place to Belong: A Comprehensive Review of Adolescent and Young Adult Surgical Oncology Care. Annals of surgical oncology 74.3 32 Imaging of developmental, inflammatory, and benign or malignant neoplastic petrous apex lesions in children: what the radiologist needs to know. La Radiologia medica 55.5
PATIENT-FRIENDLY SUMMARY

Long-term efficacy and safety of cannabidiol in patients with treatment-resistant focal epilepsies treated in the Expanded Access Program.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic